Abiraterone

Abiraterone

Drugbox
IUPAC_name = (3"S",8"R",9"S",10"R",13"S", 14"S")-10,13-Dimethyl-17-(3-pyridinyl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro- 1"H"-cyclopenta ["a"] phenanthren-3-ol



width = 175



width2 = 220
CAS_number = 154229-19-3
ATC_prefix =
ATC_suffix =
PubChem = 132971
DrugBank =
C=24|H=31|N=1|O=1
molecular_weight = 349.51 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Abiraterone is a drug currently under investigation for use in prostate cancer. It blocks the formation of testosterone by inhibiting CYP17A1 (CYP450c17), an enzyme also known as 17α-hydroxylase/17,20 lyase. [cite journal |author=Attard G, Belldegrun AS, de Bono JS |title=Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer |journal=BJU Int. |volume=96 |issue=9 |pages=1241–6 |year=2005 |pmid=16287438 |doi=10.1111/j.1464-410X.2005.05821.x] This enzyme is involved in the formation of DHEA and androstenedione, which may ultimately be metabolized into testosterone. Cougar Biotechnology are the biotechnology company conducting the research.cite web | url = http://www.cougarbiotechnology.com/cb7630.html | title = Abiraterone Acetate (CB7630) | author = | authorlink = | coauthors = | date = | format = | work = Research and Development Pipeline | publisher = Cougar Biotechnology, Inc. | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-08-20]

Clinical studies

The first study run at the Royal Marsden Hospital, London, in patients who had not received chemotherapy reported that abiraterone acetate induced decline in prostate specific antigen in up to 70% of patients as well as radiological shrinkage of tumors, symptom improvement, normalization of lactate dehydrogenase.cite journal | author = Attard G, Reid AHM, Yap TA, Raynaud F, Dowsett M, Settatree S, Barrett M, Parker C, Martins V, Folkerd E, Clark J, Cooper CS, Kaye SB, Dearnaley D, Lee G, de Bono JS | title = Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven | url = | journal = Journal of Clinical Oncology | volume = 26 | issue = | pages = | year = 2008 | month = | pmid = 18645193| doi = 10.1200/JCO.2007.15.9749 ] However others have cautioned that it is too early to know whether abiraterone treatment will have long term benefit.cite journal | author = Cole A | title = Cancer expert doubts claims about prostate cancer trial | journal = BMJ | volume = 337 | issue = | pages = a979 | year = 2008 | pmid = 18653636 | doi = 10.1136/bmj.a979 | url = ] cite journal | author = Attard G, Reid AH, Dearnaley D, De Bono JS | title = New prostate cancer drug: Prostate cancer's day in the sun | journal = BMJ | volume = 337 | issue = | pages = a1249 | year = 2008 | pmid = 18694888 | doi = 10.1136/bmj.a979 | url = http://www.bmj.com/cgi/eletters/337/jul24_3/a979#199727 ]

Results of two Phase II trials indicate that abiraterone may reduce prostate specific antigen (PSA) levels, as well as shrink tumors. [cite web | url = http://www.esmo.org/news/?news_id=97 | title = Hormone inhibitor promising for hard-to-treat prostate cancer | author = | date = 2007-07-08 | work = Press release | publisher = European Society for Medical Oncology | pages = | language = | doi = | quote = | accessdate = 2008-07-22 ] Many of the 21 men in the Phase II trial reported significant improvements in their quality of life and several were able to stop taking morphine, used to control the pain caused after the cancer spread into their bones.cite web | url = http://news.bbc.co.uk/2/hi/health/7502238.stm | title = Drug for deadly prostate cancer | author = | authorlink = | coauthors = | date = 2008-07-21 | format = | work = Health | publisher = BBC NEWS | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-08-20]

A Phase III trial is planned for 2008.cite web | url = http://www.clinicaltrials.gov/ct2/show/NCT00638690 | title = NCT00638690 | author = | authorlink = | coauthors = | date = | format = | work = | publisher = ClinicalTrials.gov | pages = | language = | archiveurl = | archivedate = | quote = Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | accessdate = 2008-08-22]

References

News reports

*
*


Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Look at other dictionaries:

  • abiraterone — noun /abɪˈra.tə.roᵿn/ A pyridine substituted sterol used as a drug against prostate cancer …   Wiktionary

  • Prostate cancer — is a disease in which cancer develops in the prostate, a gland in the male reproductive system. It occurs when cells of the prostate mutate and begin to multiply out of control. These cells may spread (metastasize) from the prostate to other… …   Wikipedia

  • Management of prostate cancer — Treatment for prostate cancer may involve active surveillance, surgery, radiation therapy including brachytherapy (prostate brachytherapy) and external beam radiation therapy, High intensity focused ultrasound (HIFU), chemotherapy, cryosurgery,… …   Wikipedia

  • Abirateron — Strukturformel Allgemeines Freiname Abirateron Andere Namen …   Deutsch Wikipedia

  • prostate cancer — Malignant tumour of the prostate gland. Prostate cancer commonly occurs in men over age 50. Symptoms include frequent or painful urination, blood in the urine, sexual dysfunction, swollen lymph nodes in the groin, and pain in the pelvis, hips,… …   Universalium

  • Nicholas J. Vogelzang — Nicholas J. Vogelzang, M.D. Born December 13, 1949(1949 12 13) Holland, Michigan Alma mater University of Illinois School of Medicine …   Wikipedia

  • Testosterone — For the film, see Testosterone (film). Testosterone Systematic (IUPAC) name …   Wikipedia

  • Androgen — Androgen, also called androgenic hormone or testoid, is the generic term for any natural or synthetic compound, usually a steroid hormone, that stimulates or controls the development and maintenance of male characteristics in vertebrates by… …   Wikipedia

  • Methyltestosterone — Systematic (IUPAC) name 17b hydroxy 17a methylandrost 4 ene 3 one Clinical data Trade names Virilo …   Wikipedia

  • Spironolactone — Systematic (IUPAC) name 7α Acetylthio 3 oxo 17α pregn 4 ene 21,17 carbolactone OR (1 S,2R,2 R,9 R,10 R,11 S,15 S) 9 (acetylsulfanyl) 2 ,15 dimethylspiro[oxolane 2,14 tetracyclo[8.7.0.0 …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”